期刊论文详细信息
Gut Pathogens
Cocktails of probiotics pre-adapted to multiple stress factors are more robust under simulated gastrointestinal conditions than their parental counterparts and exhibit enhanced antagonistic capabilities against Escherichia coli and Staphylococcus aureus
Mapitsi Silvester Thantsha1  Moloko Gloria Mathipa1 
[1] Department of Microbiology and Plant Pathology, New Agricultural Sciences Building, University of Pretoria, Pretoria 0002, South Africa
关键词: Probiotics;    Multi- stress;    Lactobacillus;    Gastrointestinal;    Bifidobacterium;    Antipathogenic;   
Others  :  1133802
DOI  :  10.1186/s13099-015-0053-5
 received in 2014-11-28, accepted in 2015-02-13,  发布年份 2015
PDF
【 摘 要 】

Background

The success of the probiotics in delivery of health benefits depends on their ability to withstand the technological and gastrointestinal conditions; hence development of robust cultures is critical to the probiotic industry. Combinations of probiotic cultures have proven to be more effective than the use of single cultures for treatment and prevention of heterogeneous diseases. We investigated the effect of pre- adaptation of probiotics to multiple stresses on their stability under simulated gastrointestinal conditions and the effect of their singular as well as their synergistic antagonistic effect against selected enteric pathogens.

Methods

Probiotic cultures were inoculated into MRS broth adjusted to pH 2 and incubated for 2 h at 37°C. Survivors of pH 2 were subcultured into 2% bile acid for 1 h at 37°C. Cells that showed growth after exposure to 2% bile acid for 1 h were finally inoculated in fresh MRS broth and incubated at 55°C for 2 h. The cells surviving were then used as stress adapted cultures. The adapted cultures were exposed to simulated gastrointestinal conditions and their non- adapted counterparts were used to compare the effects of stress adaptation. The combination cultures were tested for their antipathogenic effects on Escherichia coli and Staphylococcus aureus.

Results

Acid and bile tolerances of most of the stress-adapted cells were higher than of the non-adapted cells. Viable counts of all the stress-adapted lactobacilli and Bifidobacterium longum LMG 13197 were higher after sequential exposure to simulated gastric and intestinal fluids. However, for B. longum Bb46 and B. bifidum LMG 13197, viability of non-adapted cells was higher than for adapted cells after exposure to these fluids. A cocktail containing L. plantarum + B. longum Bb46 + B. longum LMG 13197 best inhibited S. aureus while E. coli was best inhibited by a combination containing L. acidophilus La14 150B + B. longum Bb46 + B. bifidum LMG 11041. A cocktail containing the six non- adapted cultures was the least effective in inhibiting the pathogens.

Conclusion

Multi-stress pre-adaptation enhances viability of probiotics under simulated gastrointestinal conditions; and formulations containing a mixture of multi stress-adapted cells exhibits enhanced synergistic effects against foodborne pathogens.

【 授权许可】

   
2015 Mathipa and Thantsha; licensee BioMed Central.

【 预 览 】
附件列表
Files Size Format View
20150304181816341.pdf 1237KB PDF download
Figure 4. 53KB Image download
Figure 3. 53KB Image download
Figure 2. 28KB Image download
Figure 1. 34KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

【 参考文献 】
  • [1]Ruiz L, Ruas-Madiedo P, Gueimonde M, De los Reyes-Gavilan CG, Margolles A, Sanchez B: How do bifidobacteria counteract environmental challenges? Mechanisms involved and physiological consequences. Genes Nutr 2011, 6:307-18.
  • [2]Bäckhed F, Crawford PA: Coordinated regulation of the metabolome and lipidome at the host-microbial interface. Biochem Biophys Acta 2010, 180:240-5.
  • [3]Fuller R: Probiotics in man and animals. J Appl Bacteriol 1989, 66:365-78.
  • [4]Gibson GR, McCartney AL, Rastall RA: Prebiotics and resistance to gastrointestinal infections. Br J Nutri 2005, 93:31-5.
  • [5]de Vrese M, Stegelmann A, Richter B, Fenselau S, Laue C, Schrezenmeir J: Probiotics—compensation for lactase insufficiency. Am J Clin Nutr 2001, 73:421-9.
  • [6]Pochapin M: The effect of probiotics on clostridium difficile diarrhea. Am J Gastroenterol 2000, 95:11-3.
  • [7]Isolauri E, Juntunen M, Rautanen T, Sillanaukee P, Koivula T: A human Lactobacillus strain (Lactobacillus caseisp strain GG) promotes recovery from acute diarrhea in children. Pediatrics 1991, 88:90-7.
  • [8]Collins MD, Gibson GR: Probiotics, prebiotics and synbiotics: approaches for modulating the microbial ecology of the gut. Am J Clin Nutr 1999, 69:1025-7.
  • [9]Simmering R, Blaut M: Pro- and prebiotics – the tasty guardian angels? Appl Microbiol Biotechnol 2001, 55:19-28.
  • [10]Heller KJ: Probiotic bacteria in fermented foods: product characteristics and starter organisms. Am J Clin Nutr 2001, 73:374-9.
  • [11]Shah N: Probiotic Bacteria: Selective Enumeration and Survival in Dairy Foods. J Dairy Sci 2000, 83:894-907.
  • [12]Teixeira P, Castro H, Kirby R: Inducible thermo-tolerance in Lactobacillus bulgaricus. Lett Appl Microbiol 1994, 18:218-21.
  • [13]Teixeira P, Castro H, Kirby R: Spray drying as a method for preparing concentrated cultures of Lactobacillus bulgaricus. J Appl Bacteriol 1995, 78:456-62.
  • [14]Chapman CM, Gibson GR, Rowland I: Health benefits of probiotics: are mixtures more effective than single strains? Eur J Nutr 2011, 50(1):1-17.
  • [15]Kim JY, Kwon JH, Ahn SH, Lee SI, Han YS, Choi YO, et al.: Effect of probiotic mix (Bifidobacterium bifidum, Bifidobacterium lactis, Lactobacillus acidophilus) in the primary prevention of eczema: a double-blind, randomized, placebo-controlled trial. Pediatr Allergy Immunol 2010, 21:386-93.
  • [16]Miele E, Pascarella F, Giannetti E, Quaglietta L, Baldassano RN, Staiano A: Effect of a probiotic preparation (VSL#3) on induction and maintenance of remission in children with ulcerative colitis. Am J Gastroenterol 2009, 104:437-43.
  • [17]DeMilliano I, Tabbers MM, van der Post JA, Benninga MA: Is a multispecies probiotic mixture effective in constipation during pregnancy?’A pilot study’. Nutr J 2012, 11:80-7. BioMed Central Full Text
  • [18]Talebia A, Amirzadeh B, Mokhtari B, Gahri H: Effects of a multi-strain probiotic (PrimaLac) on performance and antibody responses to Newcastle disease virus and infectious bursal disease virus vaccination in broiler chickens. Avian Path 2008, 37:509-12.
  • [19]Charteris WP, Kelly PM, Morelli L, Collins JK: Development and application of an in vitro methodology to determine the transit tolerance of potentially probiotic Lactobacillus and Bifidobacterium species in the upper human gastrointestinal tract. J Appl Microbiol 1998, 84:759-68.
  • [20]Gueimonde M, Delgado S, Mayo B, Ruas-Madiedo P, Margolles A, Reyes-Gavilan CG D l: Viability and diversity of probiotic Lactobacillus and Bifidobacterium populations included in commercial fermented milks. Food Res Int 2004, 37:839-50.
  • [21]Dunne C, O’Mahony L, Murphy L, Thornton G, Morrissey D, O’Halloran S, et al.: In vitro selection criteria for probiotic bacteria of human origin: correlation with in vivo findings. Am J Clin Nutr 2001, 73:386-92.
  • [22]Betoret E, Betoret N, Vidal D, Fito P: Functional foods development: trends and technologies. Trends Food Sci Technol 2011, 22:498-508.
  • [23]Gueimonde M, Reyes-Gavilan CG D l, Sanchez B: Stability of lactic acid bacteria in foods and supplements. In Lactic acid bacteria: microbiological and functional aspects. 4th edition. Edited by Lahtinen S, Ouwehand AC, Salminen S, Wright A. CRC Press, Taylor & Francis Group, Boca Raton, FL; 2012:361-83.
  • [24]Sanz Y: Ecological and functional implications of the acid adaptation ability of Bifidobacterium: A way of selecting improved probiotic strains. Int Diary J 2007, 17:1284-9.
  • [25]Lorca GL, de Valdez GF: A low-pH-inducible, stationary-phase acid tolerance response in Lactobacillus acidophilus CRL 639. Curr Microbiol 2001, 42:21-5.
  • [26]Corcoran BM, Ross RP, Fitzgerald GF, Dockery P, Stanton C: Enhanced survival of GroESL-overproducing Lactobacillus paracasei NFBC 338 under stressful conditions induced by drying. Appl Environ Microbiol 2006, 72:5104-7.
  • [27]Gotcheva V, Hristozova E, Hristozova T, Guo M, Roshkova Z, Angelov A: Assessment of potential probiotic properties of lactic acid bacteria and yeast strains. Food Biotechnol 2002, 16:211-25.
  • [28]Jin LZ, Ho YW, Abdullah N, Jalaludin S: Acid and bile tolerance of Lactobacillus isolated from chicken intestine. Letts Appl Microbiol 1998, 27:183-5.
  • [29]Lorca GL, de Valdez GF, Ljungh A: Characterization of the protein-synthesis dependent adaptive acid tolerance response in Lactobacillus acidophilus. J Mol Microbiol Biotechnol 2002, 4:525-32.
  • [30]Sumeri I, Arike L, Stekolštšikova J, Uusna R, Adamberg S, Adamberg K, et al.: Effect of stress pre- treatment on survival of probiotic bacteria in gastrointestinal tract simulator. Appl Microbiol Biotechnol 2010, 86:1925-31.
  • [31]Nag A, Das S: Improving ambient temperature stability of probiotics with stress adaptation and fluidized bed drying. J Func Foods 2013, 5:170-7.
  • [32]Jamalifar H, Bigdeli B, Nowroozi J, Zolfaghari HS, Fazeli MR: Selection for autochthonous bifidobacteial isolates adapted to simulated gastrointestinal fluid. DARU 2010, 18:57-63.
  • [33]Park YK, So JS, Heo TR: Acid adaptation promotes survival of Bifidobacterium breve against environmental stresses. Foods Biotechnol 1995, 4:226-30.
  • [34]Desmond C, Ross RP, O’Callaghan E, Fitzgerald G, Stanton C: Improved survival of Lactobacillus paracasei NFBC 338 in spray-dried powders containing gum acacia. J Appl Microbiol 2002, 93:1003-11.
  • [35]Collado MC, Gueimonde M, Sanz Y, Salminen S: Adhesion properties and competitive pathogen exclusion ability of bifidobacteria with acquired acid resistance. J Food Prot 2006, 69:1675-9.
  • [36]Bezkorovainy A: Probiotics: determinants of survival and growth in the gut. Am J Clin Nutri 2001, 73(S):399S-405.
  • [37]Kim WS, Perl L, Park JH, Tandianus JE, Dunn NW: Assessment of stress response of the probiotic Lactobacillus acidophilus. Curr Microbiol 2001, 43:346-50.
  • [38]Sánchez B, Fernández-García M, Margolles A, Reyes-Gavilán CG D l, Ruas-Madiedo P: Technological and probiotic selection criteria of a bile-adapted Bifidobacterium animalis subsp. lactis strain. Int Dairy J 2010, 20:800-5.
  • [39]Lin WH, Yu B, Jang SH, Tsen HY: Different probiotic properties for Lactobacillus fermentum strains isolated from swine and poultry. Anaerobe 2007, 13:107-13.
  • [40]Maus JE, Ingham SC: Employment of stressful conditions during culture production to enhance subsequent cold- and acid-tolerance of bifidobacteria. J Appl Microbiol 2004, 95:146-54.
  • [41]Gilliland SE, Staley TE, Bush LJ: Importance of bile tolerance of Lactobacillus acidophilus used as dietary adjunct. J Dairy Sci 1984, 67:3045-51.
  • [42]Fernández MF, Boris S, Barbés C: Probiotic properties of human lactobacilli strains to be used in the gastrointestinal tract. J Appl Microbiol 2003, 94:449-55.
  • [43]Ruas-Madiedo P, Hernandez-Barranco A, Margolles A, Reyes-Gavilan CG D l: A bile salt-resistant derivative of Bifidobacterium animalis has an altered fermentation pattern when grown on glucose and maltose. Appl Environ Microbiol 2005, 71:6564-70.
  • [44]Huang Y, Adams MC: In vitro assessment of the upper gastrointestinal tolerance of potential probiotic dairy propionibacteria. Int J Food Microbiol 2004, 91:253-60.
  • [45]Visozo- Pinto MG, Franz CMAP, Schillinger U, Holzapfel WH: Lactobacillus spp. with in- vitro probiotic properties from human faeces and traditional fermented products. Int J Food Microbiol 2006, 109:2205-14.
  • [46]Pochart P, Marteau P, Bouhnik Y, Goderel I, Bourlioux P, Rambaud JC: Survival of bifidobacteria ingested in a fermented milk during passage in the upper gastrointestinal tract: an in vivo study using intestinal perfusion. Am J Clin Nutr 1992, 55:78-80.
  • [47]Drouault S, Juste C, Marteau P, Renault P, Corthier G: Oral treatment with Lactococcus lactis expressing Staphylococcus hyicus lipase enhances lipid digestion in pigs with induced pancreatic insufficiency. Appl Environ Microbiol 2002, 68:3166-8.
  • [48]Berrada N, Lemeland JF, Laroche G, Thouvenot P, Piaia M: Bifidobacterium from fermented milks: survival during gastric transit. J Dairy Sci 1991, 74:409-13.
  • [49]Rakita RM: Intracellular activity, potential clinical uses of antibiotics. ASM News 1998, 64:570-5.
  • [50]Resta- Lenert S, Barret KE: Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive Escherichia coli (EIEC). Gut 2003, 52:988-97.
  • [51]Boudeau J, Glasser AL, Julien S, Colombel JF, Darfeuille-Michaud A: Inhibitory effect of probiotic Escherichia coli strain Nissle 1917 on adhesion to and invasion of intestinal epithelial cells by adherent–invasive E. coli strains isolated from patients with Crohn’s disease. Aliment Pharmacol Ther 2003, 18:45-56.
  • [52]Canzi E, Guglielmetti S, Mora D, Tamagnini I, Parini C: Conditions affecting cell surface properties of human intestinal bifidobacteria. Antonie Van Leeuwenhoek 2005, 88:207-19.
  • [53]Gueimonde M, Jalonen L, He F, Hiramatsu M, Salminen S: Adhesion and competitive inhibition and displacement of human enteropathogens by selected lactobacilli. Food Res Int 2006, 39:467-71.
  • [54]Gagnon M, Kheadr EE, LeBlay G, Fliss I: In vitro inhibition of Escherichia coli O157: H7 by bifidobacteria strains of human origins. Int J Food Microbiol 2004, 92:69-78.
  • [55]Drago L, Gismondo MR, Lombardi A, de Haen C, Gozzini L: Inhibition of in vitro growth of enteropathogens by new Lactobacillus isolates of human intestinal origin. FEMS Microbiol Lett 1997, 153(2):455-63.
  • [56]Collado MC, Meriluoto J, Salminen S: In vitro analysis of probiotic strain combinations to inhibit pathogen adhesion to human intestinal mucus. Food Res Int 2007, 40:629-36.
  • [57]Brashears MM, Jaroni D, Trimble J: Isolation, selection, and characterization of lactic acid bacteria for a competitive exclusion product to reduce shedding of Escherichia coli O157:H7 in cattle. J Food Protec 2003, 66:355-63.
  • [58]Tsai CC, Lin PP, Hsieh YM: Three Lactobacillus strains from healthy infant stool inhibit enterotoxigenicEscherichia coli grown in vitro. Anaerobe 2007, 14:1-7.
  文献评价指标  
  下载次数:16次 浏览次数:13次